Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jan 14;5(4):400-4.
doi: 10.1021/ml4005304. eCollection 2014 Apr 10.

C-ring cannabinoid lactones: a novel cannabinergic chemotype

Affiliations

C-ring cannabinoid lactones: a novel cannabinergic chemotype

Rishi Sharma et al. ACS Med Chem Lett. .

Abstract

As a part of our controlled-deactivation ligand development project, we recently disclosed a series of (-)-Δ(8)-tetrahydrocannabinols (THCs) with a metabolically labile ester group at the 2'-position of the side chain. Now, we have replaced the C-ring in the classical THC structure with a hydrolyzable seven-membered lactone. One of the synthesized analogues binds with high affinity to the CB1 receptor (K i = 4.6 nM) and exhibits much lower affinities for the mCB2 and the hCB2. Also, in vitro functional characterization found the compound to be an agonist at rCB1. Consistent with our rational design, the lead cannabinergic lactone identified here is susceptible to metabolic inactivation by plasma esterases, while the respective acid metabolite is inactive at CB receptors. These results are highlighted with molecular modeling of the two regiosomeric lactones.

Keywords: Baeyer−Villiger rearrangement; Cannabinoids; lactones.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Design and enzymatic inactivation of cannabinergic C-ring lactones.
Scheme 1
Scheme 1. Synthesis of Cannabinergic C-Ring Lactones
Reagents and conditions: (a) 3, p-TSA, CHCl3, 0 °C to rt, 72%; (b) TMSOTf, CH2Cl2/MeNO2, 0 °C to rt, 73%; (c) Ac2O, pyridine, CH2Cl2, rt, 90%; (d) m-CPBA, CH2Cl2, 0 °C to rt, 97%; (e) LiOH, THF/H2O, 0 °C, 32–53%; (f) chromatographic separation; (g) CH3SO3H, DMAP, toluene, rt, 44%; (h) CH3SO3H, DMAP, toluene, rt, 79%.
Chart 1
Chart 1. Structure of the Probable Criegee Intermediate 12 and Rearrangement Pathways Leading to Regioisomeric Lactones 7a and 7b
Figure 2
Figure 2
Lowest energy conformers of the Criegee intermediate 12 in which the peroxide group occupies the equatorial (A, calculated energy: −66.069 kcal/mol) or the axial (B, calculated energy: −67.074 kcal/mol) position of the cyclohexane C-ring. Oxygen atoms are presented in red. Aromatic rings are partially displayed, while hydrogen atoms are not shown. In these almost equienergetic conformers, the C8 carbon is in a position antiperiplanar to the oxygen–oxygen bond of the peroxide (dihedral angle O–O–C9–C8: −177.9° for A and +173.7° for B) and is expected to have a higher migratory aptitude when compared to C10.
Figure 3
Figure 3
Lowest energy conformers for compounds 10 (A) and 11 (B). The C3 dimethylheptyl side chains are partially displayed, while the 1-hydroxyl group is tilted furthest from the viewer. The white grid shows the van der Waals surface for the ester group. The red contours represent the electron density surfaces of the oxygen atoms.

Similar articles

  • Probing the carboxyester side chain in controlled deactivation (-)-δ(8)-tetrahydrocannabinols.
    Nikas SP, Sharma R, Paronis CA, Kulkarni S, Thakur GA, Hurst D, Wood JT, Gifford RS, Rajarshi G, Liu Y, Raghav JG, Guo JJ, Järbe TU, Reggio PH, Bergman J, Makriyannis A. Nikas SP, et al. J Med Chem. 2015 Jan 22;58(2):665-81. doi: 10.1021/jm501165d. Epub 2014 Dec 16. J Med Chem. 2015. PMID: 25470070 Free PMC article.
  • Controlled-deactivation cannabinergic ligands.
    Sharma R, Nikas SP, Paronis CA, Wood JT, Halikhedkar A, Guo JJ, Thakur GA, Kulkarni S, Benchama O, Raghav JG, Gifford RS, Järbe TU, Bergman J, Makriyannis A. Sharma R, et al. J Med Chem. 2013 Dec 27;56(24):10142-57. doi: 10.1021/jm4016075. Epub 2013 Dec 10. J Med Chem. 2013. PMID: 24286207 Free PMC article.
  • Novel adamantyl cannabinoids as CB1 receptor probes.
    Thakur GA, Bajaj S, Paronis C, Peng Y, Bowman AL, Barak LS, Caron MG, Parrish D, Deschamps JR, Makriyannis A. Thakur GA, et al. J Med Chem. 2013 May 23;56(10):3904-21. doi: 10.1021/jm4000775. Epub 2013 May 14. J Med Chem. 2013. PMID: 23621789 Free PMC article.
  • Behavioral effects of cannabinoid agents in animals.
    Chaperon F, Thiébot MH. Chaperon F, et al. Crit Rev Neurobiol. 1999;13(3):243-81. doi: 10.1615/critrevneurobiol.v13.i3.20. Crit Rev Neurobiol. 1999. PMID: 10803637 Review.
  • CB2 receptor ligands.
    Huffman JW. Huffman JW. Mini Rev Med Chem. 2005 Jul;5(7):641-9. doi: 10.2174/1389557054368844. Mini Rev Med Chem. 2005. PMID: 16026310 Review.

Cited by

References

    1. Mechoulam R.; Hanus L. A historical overview of chemical research on cannabinoids. Chem. Phys. Lipids 2000, 108, 1–13. - PubMed
    1. Devane W. A.; Dysarz F. A. III; Johnson M. R.; Melvin L. S.; Howlett A. C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34, 605–613. - PubMed
    1. Munro S.; Thomas K. L.; Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365, 61–65. - PubMed
    1. Pavlopoulos S.; Thakur G. A.; Nikas S. P.; Makriyannis A. Cannabinoid receptors as therapeutic targets. Curr. Pharm. Des. 2006, 12, 1751–1769. - PubMed
    1. Pertwee R. G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 1997, 74, 129–180. - PubMed